Coudert J, Antezana G, Bedu M
Rev Pneumol Clin. 1985;41(4):264-72.
High-altitude pulmonary edema has the following clinical features: it occurs in young healthy subjects exposed to altitudes usually above 3,000 m; it is favored by rapid ascent, exercise, cold, and sleep; it can give a deceptive clinical picture because of the patchy distribution of the edema. Hemodynamically, severe pulmonary arterial hypertension (PAH) occurs without increase in wedge pressure or left atrial pressure. Under treatment (rest, oxygen, diuretics), the condition rapidly improves. The physiopathological mechanism of this non-cardiogenic edema is complex and not yet fully defined: PAH essentially stems from hyperreactivity of the pulmonary circulation towards hypoxic arteriolar vasoconstriction, increase in pulmonary blood volume, and pulmonary microthrombosis. Postulated mechanisms involving mixed intra-alveolar edema with high pressure and increased permeability are based on transarterial leakage, over perfusion with endothelial injury, and an increase of permeability in relation to histamine and vasoactive polypeptides. Prevention relies, for a large part, on the identification of HAPE-prone subjects, slow ascent to high altitude, moderate physical activity, warm clothing, and prior administration of acetazolamide.
它发生在通常暴露于海拔3000米以上的年轻健康受试者中;快速上升、运动、寒冷和睡眠会诱发该病;由于水肿呈斑片状分布,其临床表现可能具有欺骗性。从血流动力学角度来看,会出现严重的肺动脉高压(PAH),而楔压或左心房压力并无升高。在接受治疗(休息、吸氧、使用利尿剂)后,病情会迅速改善。这种非心源性水肿的生理病理机制较为复杂,尚未完全明确:PAH主要源于肺循环对低氧性小动脉血管收缩的高反应性、肺血容量增加以及肺微血栓形成。推测的机制包括高压性与通透性增加的混合性肺泡内水肿,其基于经动脉渗漏、伴有内皮损伤的过度灌注以及与组胺和血管活性多肽相关的通透性增加。预防在很大程度上依赖于识别易患高原肺水肿的受试者、缓慢上升至高原、适度体育活动、保暖衣物以及预先给予乙酰唑胺。